News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
567,510 Results
Type
Article (21729)
Company Profile (173)
Press Release (545606)
Multimedia
Podcasts (31)
Webinars (11)
Section
Business (183487)
Career Advice (931)
Deals (27694)
Drug Delivery (39)
Drug Development (64912)
Employer Resources (63)
FDA (11916)
Job Trends (10229)
News (270443)
Policy (23047)
Tag
2025 Best Places to Work (10)
2026 Best Places to Work (16)
2027 BioCapital Standard (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Standard (2)
40 Under 40 (1)
Academia (1518)
Accelerated approval (45)
ADA (32)
Adcomms (9)
Allergies (138)
Alliances (38825)
ALS (194)
Alzheimer's disease (1348)
Antibody-drug conjugate (ADC) (502)
Approvals (12659)
Artificial intelligence (680)
ASCO (214)
Autoimmune disease (365)
Automation (54)
Bankruptcy (279)
Belgium (14)
Best Places to Work (8332)
BIO (50)
Biologics (80)
BIOSECURE Act (2)
Biosimilars (174)
BioSpace Insights (56)
Biotechnology (109)
Bispecific (46)
Bladder cancer (184)
Brain cancer (50)
Breast cancer (701)
Cancer (5337)
Cardiovascular disease (326)
Career advice (760)
Career pathing (14)
CAR-T (264)
CDC (51)
CDMO (75)
Celiac Disease (4)
Cell-line development (1)
Cell therapy (738)
Cervical cancer (57)
Clinical research (58324)
Collaboration (1865)
Commercialization (44)
Company closure (1)
Compensation (1673)
Complete response letters (44)
COVID-19 (1637)
CRISPR (121)
CRO (1)
C-suite (1047)
Cystic fibrosis (132)
Data (8443)
Decentralized trials (1)
Denatured (11)
Depression (122)
Dermatology (143)
Diabetes (507)
Diagnostics (5052)
Digital health (56)
Diversity (5)
Diversity, equity & inclusion (17)
Drug discovery (305)
Drug pricing (48)
Drug shortages (7)
Duchenne muscular dystrophy (218)
Earnings (78126)
Editorial (32)
Employer branding (7)
Employer resources (60)
ESMO (309)
Events (98421)
Executive appointments (897)
Eye disease (11)
FDA (15587)
Fibrodysplasia Ossificans Progressiva (13)
Fragile X (4)
Friedreich's ataxia (23)
Frontotemporal dementia (32)
Funding (1462)
Gene editing (225)
Generative AI (57)
Gene therapy (539)
GLP-1 (543)
Government (2592)
Grass and pollen (2)
Guidances (334)
Healthcare (11834)
Hematology (142)
HIV (84)
Huntington's disease (42)
Idiopathic pulmonary fibrosis (6)
IgA nephropathy (101)
Immunology and inflammation (181)
Immuno-oncology (101)
Indications (234)
Infectious disease (1946)
Inflammatory bowel disease (188)
Inflation Reduction Act (8)
Influenza (127)
Intellectual property (310)
Interviews (139)
IPO (13329)
IRA (14)
Job creations (2298)
Job search strategy (663)
JPM (9)
Kidney cancer (20)
Kidney disease (114)
Labor market (22)
Layoffs (166)
Leadership (12)
Legal (5847)
Licensing (88)
Liver cancer (63)
Longevity (57)
Lung cancer (747)
Lung diease (14)
Lymphoma (342)
Machine learning (50)
Management (25)
Manufacturing (786)
Marketing (31)
MASH (153)
Medical affairs (2)
Medical device (9709)
Medtech (9928)
Mergers & acquisitions (15604)
Metabolic disorders (1075)
mRNA (172)
Multiple sclerosis (174)
Multispecific (4)
NASH (7)
Netherlands (12)
Neurodegenerative disease (358)
Neuropsychiatric disorders (60)
Neuroscience (2680)
Neurotech (3)
NextGen: Class of 2026 (3981)
Non-profit (1735)
Now hiring (6)
Obesity (382)
Opinion (99)
Ovarian cancer (235)
Pain (230)
Pancreatic cancer (302)
Parkinson's disease (306)
Partnered (19)
Patents (603)
Patient advocacy (4)
Patient recruitment (718)
Patient selection (86)
Peanut (41)
People (46733)
Peptides (39)
Pharmaceutical (36)
Pharmacy benefit managers (18)
Phase 1 (19861)
Phase 2 (25647)
Phase 3 (17578)
Pipeline (10912)
Policy (162)
Postmarket research (1910)
Preclinical (8712)
Press Release (48)
Prostate cancer (266)
Psychedelics (29)
Radioligand (1)
Radiopharmaceuticals (254)
Rare diseases (891)
Real estate (3572)
Recruiting (24)
Regenerative medicine (31)
Regulatory (19495)
Reports (34)
Research institute (1540)
Resumes & cover letters (186)
Rett syndrome (52)
RNA editing (24)
RSV (65)
Schizophrenia (131)
Series A (263)
Series B (188)
Service/supplier (5)
Sickle cell disease (107)
Special edition (4)
Spinal muscular atrophy (127)
Sponsored (25)
Startups (2588)
Stem cells (8)
Stomach cancer (5)
Substance use disorders (17)
Supply chain (76)
Switzerland (8)
Tariffs (17)
The Weekly (20)
Vaccines (761)
Venture capital (49)
Weight loss (152)
Wet AMD (5)
Women's health (129)
Worklife (2)
Date
Last 7 days (713)
Last 30 days (2682)
Last 365 days (22966)
2026 (20741)
2025 (22722)
2024 (26974)
2023 (30933)
2022 (40057)
2021 (42949)
2020 (39472)
2019 (29236)
2018 (22037)
2017 (22596)
2016 (21874)
2015 (28198)
2014 (24700)
2013 (21002)
2012 (22793)
2011 (23157)
2010 (22273)
Location
Africa (428)
Alabama (88)
Alaska (3)
Arizona (360)
Arkansas (15)
Asia (25936)
Australia (4000)
California (14619)
Canada (3715)
China (1075)
Colorado (595)
Connecticut (568)
Delaware (321)
Europe (44977)
Florida (2135)
Georgia (460)
Hawaii (4)
Idaho (47)
Illinois (928)
India (80)
Indiana (434)
Iowa (29)
Japan (557)
Kansas (114)
Kentucky (44)
Louisiana (41)
Maine (33)
Maryland (1617)
Massachusetts (10117)
Michigan (363)
Minnesota (678)
Mississippi (6)
Missouri (101)
Montana (30)
Nebraska (18)
Nevada (154)
New Hampshire (69)
New Jersey (3413)
New Mexico (17)
New York (3474)
North Carolina (1598)
North Dakota (8)
Northern California (7490)
Ohio (359)
Oklahoma (16)
Oregon (22)
Pennsylvania (2662)
Puerto Rico (25)
Rhode Island (46)
South America (590)
South Carolina (83)
South Dakota (1)
Southern California (6021)
Tennessee (153)
Texas (2399)
United States (48492)
Utah (435)
Vermont (1)
Virginia (219)
Washington D.C. (51)
Washington State (1138)
West Virginia (3)
Wisconsin (127)
Wyoming (4)
567,510 Results for "human longevity inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Human Longevity Expands Its $1 Million Cancer Prevention Pledge to Breast Cancer
October 18, 2026
·
2 min read
Press Releases
MUSE Cells Now Available at Longevity Medical Institute®
As part of its Regenerative Neurology Program, Longevity Medical Institute® is making MUSE cell therapy available to select patients, using cells produced in-house at the Institute’s biotechnology laboratory.
September 18, 2026
·
1 min read
Press Releases
Beyond Cellular Models: Longevica Capitalizes on World’s Largest In Vivo Longevity Study to Form Star-Studded Advisory Board and Unlock Human Health-and-Lifespan Pipeline
September 29, 2026
·
7 min read
Press Releases
Insilico Medicine and Human Longevity Announce Collaboration to Co-Develop Industry-First AI Foundation Model for Longevity Science
May 26, 2026
·
5 min read
Press Releases
Longeveron to Participate in Three Longevity/Aging Investment Conferences
September 30, 2026
·
9 min read
Insights
Beyond Buzzwords in Longevity Investing
In this episode of Denatured, you’ll listen to Sergey Jakimov, managing partner at LongeVC and Artem Trotsyuk, operating partner, US, LongeVC. We speak about how developers in the longevity space should stop chasing aging as an abstract target and concentrate on specific mechanisms that can clearly tackle age-related conditions.
March 26, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Press Releases
Wellness Index Report Highlights Shift from Longevity to Root-Cause Health and Human Potential
June 3, 2026
·
1 min read
Press Releases
Immunis Wins Grand Prize in National Academy of Medicine Healthy Longevity Global Competition
October 21, 2026
·
3 min read
Press Releases
Vesalius Longevity Labs Appoints Harvey Spevak as Chairman to Accelerate Global Growth and Brand Development
Appointment Follows US$6.5 Million Strategic Financing and Strengthens Board Leadership Alongside David Adelman, Kevin Mayer, Lee Applbaum and James McRoberts
November 13, 2026
·
8 min read
Press Releases
Vesalius Longevity Labs Commences Trading Today on the Canadian Securities Exchange Under the Symbol “VLAB”
November 12, 2026
·
2 min read
1 of 56,751
Next